il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Recurrent Metastatic Malignant Neoplasm in the Leptomeninges
City of Hope Medical CenterCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
42 Active assets in the Recurrent Metastatic Malignant Neoplasm in the Leptomeninges cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid Fudan University | Phase 4 | BBB |
METHOTREXATE The First Affiliated Hospital with Nanjing Medical University | Phase 4 | BB |
TRASTUZUMAB The First Affiliated Hospital with Nanjing Medical University | Phase 2 | BB |
DEXAMETHASONE Shanghai Cancer Hospital, China | Phase 2 | B |
Lorlatinib Guangdong Association of Clinical Trials | Phase 4 | B |
View all 50 →
Same molecule, other indications
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →